The latest news from oncology events around the world
Genetic counselling is essential when dealing with individuals who are affected by, or at risk…
The Menarini Group (“Menarini”), announced important new data on selinexor at the European Hematology Association (EHA) Congress 2023.…
A targeted drug combination for patients with a type of ovarian cancer could be nearly twice as…
Updated dose expansion data of the phase I STRO-002-GM1 study were presented today by Ana Oaknin, Principal…
Ciltacabtagene autoleucel, a BCMA-targeting CAR T-cell therapy, significantly slows or stops progression of multiple myeloma…
Patients with early relapsed or refractory large B-cell lymphoma had significantly improved overall survival when treated with the chimeric…
Results from the largest prospective study of primary mediastinal B-cell lymphoma show that radiation therapy…
The SYMPLIFY study is the first large-scale evaluation of a multi-cancer early detection (MCED) test in individuals…
“For patients with stage 1 cervical cancer who are eligible for surgery, radical hysterectomy has…
Chemotherapy-induced peripheral neuropathy (CIPN) – nerve pain, tingling, or numbness in the hands or feet…